Trusted Resources: News & Meetings
Latest announcements and gatherings
Gene Therapy for Sanfilippo: Where We Are Now
Gene therapy is a promising approach for a number of rare genetic diseases as it has the potential to treat the underlying cause. Here is more information about gene therapy, its challenges, and its current status as a treatment for Sanfilippo syndrome.
Sanfilippo syndrome is caused by mutations in genes that encode for enzymes which break down long chains of sugar molecules. The goal of gene therapy for Sanfilippo is to deliver correct copies of the faulty gene to patients so that their cells can produce functional enzymes to breakdown and prevent the accumulation of these sugar molecules.
The first is that each of the four subtypes of Sanfilippo syndrome is due to a mutation in a different gene, so each subtype requires a separate target for gene therapy. In other words, one gene therapy will not work for all Sanfilippo patients.
BookmarkRelated Content
-
Orthopedic Management and Bone Marrow Transplantation for MPS Disordershttps://www.youtube.com/watch?v=ZZ49Vu5W...
-
Cure Sanfilippo FoundationCure Sanfilippo Foundation is a Not-for-...
-
A Multicenter Open-Label Extension Study of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Typ...Sanfilippo syndrome type A (mucopolysacc...
-
Open-Label Phase 1/2 Study of Vestronidase Alfa for Mucopolysaccharidosis VIIVestronidase alfa is an enzyme replaceme...
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Kathleen BuckleyKathleen Buckley is the President of the...
-
Sanfilippo Children’s Foundation – TwitterSanfilippo Childrens foundation is dedic...
Powered by
